3C Ronald Kahn,Gordon C weir,George L King,et al.Joslin糖尿病学.北京:人民卫生出版社,2007:1011.
4Ziyadeh FN,Han DC.Involvement of TGF-β and its receptors in the pathogenesis of diabetic nephropathy.Kidney Int,1997,52(supp160):7.
5Terrell TG,Working PK,Chow CP,et al.Pathology of recombinant human TGF-β1 in rats and rabbits.INT Rev Exp Pathol,1993,34B:43.
6Isaka Y,Fuijiwara Y,Ueda N,et al.Glomerulosclerosis induced by in vivo transfection of TGF-β or PDGF into rat kidney.J Clin Invest,1993,92:2597.
7Yamamoto T,Nakamura T,Noble NA,et al.Expression of TGF-β is elevated in human and experimental diabetic nephropathy.Proc Natl Acad Sci USA,1993,90:1814.
8Iwano M,Kubo A,Nishino T,et al.Quantification of glomerular TGF-β1 mRNA inpatients with diabetes mellitus.Kidney Int,1996,49:854.
9Sharma K,Jin Y,Guo J,et al.Neutralization of TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in streptozotocin-induced diabetic mice.Diabetes,1996,45:522.
10Ziyadeh FN,Hoffman BB,Han DC,et al.Long-term prevention of renal insufficiency,excess matrix gene expression,and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-beta antibody in db/db diabetic mice.Proc Natl Acad Sci USA,2000,97:8015.
